Packaging Improves Compliance - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Packaging Improves Compliance
A decade of awards shows there's no lack of good ideas for compliance packaging.


Pharmaceutical Technology


Arranging tablets in a racetrack design proved to be the answer Taro Pharmaceuticals USA, Inc. (Hawthorne, NY, http://www.taropharma.com) was seeking when Wal-Mart Stores, Inc. (Bentonville, AR, http://www.walmartstores.com) asked for a package that would help improve compliance for 5-mg warfarin, an anticoagulent, and at the same time simplify pharmacy operations. Taro worked with a contract packager to find a pocket-size carded blister design that would accommodate a 30-tablet regimen. The oval "Track Pack"design by American Health Packaging (Columbus, OH, http://www.healthpack.com) permits patients to begin the regimen on any day of the week (see Figure 2). The large, printable area on the compact package permits larger type for instructions, which improves readability. The package was recognized as the 2004 Compliance Package of the Year by HCPC. Competition judges noted, "The fact that such an outstanding design is being used with a generic drug is especially praiseworthy." Another judge's comment described the package's overall impression: "Exciting graphics, clear instructions, and a knockout compliance-prompting design make this the best package I've seen this year."

A decade of awards shows there's no lack of good ideas for compliance packaging. These concepts serve as the starting point for new packaging innovations that will make it easier for even more patients to take their medications properly.

Hallie Forcinio is Pharmaceutical Technology's Packaging Forum editor, 4708 Morningside Drive, Cleveland, OH 44109, tel. 216.351.5824, fax 216.351.5684,


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Pharmaceutical Technology,
Click here